期刊文献+

ICTP和骨钙素在乳腺癌骨转移诊断中的临床应用 被引量:4

原文传递
导出
摘要 乳腺癌是女性常见恶性肿瘤,常发生同侧腋窝淋巴结及远处脏器转移,其中最常见的为骨转移,早诊断、早治疗是提高患者生活质量,延长生存时间的前提;同时临床上对发生骨转移和未发生骨转移患者的治疗方法有很大差别。因此,寻找乳腺癌骨转移标志,对临床乳腺癌诊断与治疗有重要意义。
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2010年第10期960-962,共3页 Chinese Journal of Laboratory Medicine
基金 天津市应用基础研究计划项目资助课题(07JCYBJC09100)
  • 相关文献

参考文献17

二级参考文献44

  • 1杉山和義,韩少良.乳腺癌的肿瘤标志物[J].日本医学介绍,2005,26(2):71-73. 被引量:6
  • 2顾兴华,夏康适.骨转移癌药物治疗近况[J].国外医学(肿瘤学分册),1994,21(4):233-234. 被引量:8
  • 3李景学.骨矿物质影像学研究的新趋向[J].中华放射学杂志,1996,30(1):56-58. 被引量:17
  • 4宋三泰.乳癌内分泌治疗应该注意的几个问题[J].中国实用外科杂志,1997,17(2):70-72. 被引量:6
  • 5Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev, 2001, 27:165-176.
  • 6Johnson JR, Williams G, Pazdur R, et al. End points and United States Food and Drug Administration approval of oncology drugs. J Clin Oncol, 2003, 21 : 1404-1411.
  • 7Kinnane N. Burden of bone disease. Eur J Oncol Nuts, 2007, 11 Suppl 2 : S28-31.
  • 8Eubank WB, Mankoff DA. Evolving role of positron emission tomography in breast cancer imaging. Semin Nucl Med, 2005, 35:84-99.
  • 9Chow E, Harris K, Fan G, et al. Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol, 2007, 25: 1423-1436.
  • 10Hillner BE, Ingle JN, Chlebowski RT, et al. American Society of Clinical Oneology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oneol, 2003, 21:4042-4057.

共引文献102

同被引文献39

  • 1吴晓徽,陆汉魁.骨代谢指标在肿瘤骨转移诊治中的应用[J].肿瘤,2007,27(6):505-507. 被引量:4
  • 2Salem AM, Zohny SF, Abd El-Walab MM, et al. Predictive value of osteocalcin and beta-Crosslaps in metastatic breast cancer[ J]. Clin Bio- chem, 2007, 40(4): 1201-1208.
  • 3Takahashi S. Evaluation of cancer-induced bone diseases by bone metabolic marker[J]. Clin Calcium, 2006,16(2) : 581-590.
  • 4Jung K, Lein M, Stephan C, et al. Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and progllosfie implieatlons[J], hit J Cancer, 2004, 111 (5) : 783-791.
  • 5Brasso K, Christensen IJ, Johansen JS, et al. Prognostic value of PINP, bone alka)ine phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma[J]. Prostate, 2006, 66(5) : 503-513.
  • 6Koopmans N, De Jong I, Breeuwsma A, et al. Serum bone turnover markers ( PINP and ICTP) for the early detection of bone metastases in patients with prostate cancer: A lougltudittal approach[ J ]. J Urol, ?2007, 178(3 ptl) :849-853.
  • 7Koizumi M, Yonese J, Fukui I, et al. The serum level of the amino- terminal propeptide of type I procollagen is a sensitive marker for prostate cancer metastasis to bone[J]. BJU hat, 2001, 87(4) : 348-351.
  • 8Pollm,,un D, Siepmann S. The amino-terminal propeptide (PINP) of type 1 collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer [ J ]. Anficaneer Res, 2007,27(4A) :1853-1862.
  • 9Lorente JA, Valenzuela H, Morote J, et al. ~rum bone alkalinephosphatase levels enhance the clinical utility of prostate specific; antigen in the staging of newly diagnosed prostate cancer patients [ J ]. Eur Nutl Med, 1999, 26(6) :625-632.
  • 10Ramankulov A, Lein M, Kristiansen G, et al. Plasma osLeoponfin in comparson with bone marker8 as indicator of bone metastasis and survival outcome in patients with prostate cancer[J]. Prostate, 2007, 67 (3) :330-340.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部